Neuroendocrine tumors of the uterine cervix - Clinicopathologic study of five patients

被引:14
作者
Collinet, P
Lanvin, D
Declerck, D
Chevalier-Place, A
Leblanc, E
Querleu, D
机构
[1] Ctr Hosp Reg & Univ Lille, Hop Jeanne Flandre, Clin Gynecol Obstet & Neonatalog, F-59037 Lille, France
[2] Hop Victor Provo, Serv Anat & Cytol Pathol, F-59056 Roubaix 1, France
[3] Ctr Oscar Lambret, Dept Gynecol Oncol, F-59020 Lille, France
来源
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 2000年 / 91卷 / 01期
关键词
neuroendocrine; cervix; small cell carcinoma; chemotherapy;
D O I
10.1016/S0301-2115(99)00253-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Four main clinicopathologic features of neuroendocrine tumors (NETs) of the cervix may be stressed: primary diagnosis at an advanced stage, early nodal metastasis even for low disease, early failure of appropriate local treatment (surgery and/or radiation therapy) and aggressive clinical treatment. Five patients with NET of the uterine cervix (small cell carcinoma type) are reported (one stage I, two stages II, one stage III and one stage IV). One patient was treated by surgery combined with radiation therapy, one by surgery combined with chemotherapy and one by surgery with radiation therapy and chemotherapy. Two patients received radiation therapy alone. Three early stage patients are alive with no evidence of disease 8, 26 and 41 months after diagnosis. The two patients with advanced stage died of disease, 3 and 12 months respectively, after diagnosis. Combination chemotherapy (cisplatin and etoposide) is warranted in disseminated NETs. Neoadjuvant or adjuvant chemotherapy should be combined with radiation therapy and surgery even in early stages. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 39 条
[1]  
ABELER VM, 1994, CANCER, V73, P672, DOI 10.1002/1097-0142(19940201)73:3<672::AID-CNCR2820730328>3.0.CO
[2]  
2-R
[3]  
ALBORES-SAAVEDRA J, 1972, Patologia (Mexico City), V10, P185
[4]  
ALBORESSAAVEDRA J, 1976, CANCER, V38, P2328, DOI 10.1002/1097-0142(197612)38:6<2328::AID-CNCR2820380620>3.0.CO
[5]  
2-J
[6]  
AlboresSaavedra J, 1997, ARCH PATHOL LAB MED, V121, P34
[7]  
BARRETT RJ, 1987, CANCER, V60, P2325, DOI 10.1002/1097-0142(19871101)60:9<2325::AID-CNCR2820600935>3.0.CO
[8]  
2-G
[9]   CUTANEOUS METASTASIS OF NEUROENDOCRINE CARCINOMA OF UTERINE ORIGIN [J].
FOGACA, MF ;
FEDORCIW, BJ ;
TAHAN, SR ;
JOHNSON, R ;
FEDERMAN, M .
JOURNAL OF CUTANEOUS PATHOLOGY, 1993, 20 (05) :455-458
[10]  
Hauser H, 1995, Eur J Surg Oncol, V21, P297, DOI 10.1016/S0748-7983(95)91624-5